"World's Most Complete Market Research Reports Repository"

Global Oral Proteins and Peptides Market Insights, Forecast to 2025

This report studies the global market size of Oral Proteins and Peptides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Proteins and Peptides in these regions.
This research report categorizes the global Oral Proteins and Peptides market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.
The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.
The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.
The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.
In 2017, the global Oral Proteins and Peptides market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Oral Proteins and Peptides market based on company, product type, application and key regions.

The various contributors involved in the value chain of Oral Proteins and Peptides include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oral Proteins and Peptides include
Allergan
AstraZeneca
Biocon
Generex Biotechnology
Novo Nordisk
Synergy Pharmaceuticals
Tarsa Therapeutics
Sanofi
Hoffmann-La Roche
Synthetic Biologics
Hovione
Novartis

Market Size Split by Type
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Market Size Split by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oral Proteins and Peptides market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Oral Proteins and Peptides market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Proteins and Peptides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Proteins and Peptides with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oral Proteins and Peptides submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Proteins and Peptides are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Proteins and Peptides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Oral Proteins and Peptides Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type
1.4.2 Linaclotide
1.4.3 Plecanatide
1.4.4 Calcitonin
1.4.5 Insulin
1.4.6 Octreotide
1.5 Market by Application
1.5.1 Global Oral Proteins and Peptides Market Size Growth Rate by Application
1.5.2 Gastric & Digestive Disorders
1.5.3 Bone Diseases
1.5.4 Diabetes
1.5.5 Hormonal Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oral Proteins and Peptides Market Size
2.1.1 Global Oral Proteins and Peptides Revenue 2016-2025
2.1.2 Global Oral Proteins and Peptides Sales 2016-2025
2.2 Oral Proteins and Peptides Growth Rate by Regions
2.2.1 Global Oral Proteins and Peptides Sales by Regions
2.2.2 Global Oral Proteins and Peptides Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Oral Proteins and Peptides Sales by Manufacturers
3.1.1 Oral Proteins and Peptides Sales by Manufacturers
3.1.2 Oral Proteins and Peptides Sales Market Share by Manufacturers
3.1.3 Global Oral Proteins and Peptides Market Concentration Ratio (CR5 and HHI)
3.2 Oral Proteins and Peptides Revenue by Manufacturers
3.2.1 Oral Proteins and Peptides Revenue by Manufacturers (2016-2018)
3.2.2 Oral Proteins and Peptides Revenue Share by Manufacturers (2016-2018)
3.3 Oral Proteins and Peptides Price by Manufacturers
3.4 Oral Proteins and Peptides Manufacturing Base Distribution, Product Types
3.4.1 Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Proteins and Peptides Product Category
3.4.3 Date of International Manufacturers Enter into Oral Proteins and Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Oral Proteins and Peptides Sales by Type
4.2 Global Oral Proteins and Peptides Revenue by Type
4.3 Oral Proteins and Peptides Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Oral Proteins and Peptides Breakdown Data by Application

6 North America
6.1 North America Oral Proteins and Peptides by Countries
6.1.1 North America Oral Proteins and Peptides Sales by Countries
6.1.2 North America Oral Proteins and Peptides Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oral Proteins and Peptides by Type
6.3 North America Oral Proteins and Peptides by Application
6.4 North America Oral Proteins and Peptides by Company

7 Europe
7.1 Europe Oral Proteins and Peptides by Countries
7.1.1 Europe Oral Proteins and Peptides Sales by Countries
7.1.2 Europe Oral Proteins and Peptides Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Proteins and Peptides by Type
7.3 Europe Oral Proteins and Peptides by Application
7.4 Europe Oral Proteins and Peptides by Company

8 Asia Pacific
8.1 Asia Pacific Oral Proteins and Peptides by Countries
8.1.1 Asia Pacific Oral Proteins and Peptides Sales by Countries
8.1.2 Asia Pacific Oral Proteins and Peptides Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oral Proteins and Peptides by Type
8.3 Asia Pacific Oral Proteins and Peptides by Application
8.4 Asia Pacific Oral Proteins and Peptides by Company

9 Central & South America
9.1 Central & South America Oral Proteins and Peptides by Countries
9.1.1 Central & South America Oral Proteins and Peptides Sales by Countries
9.1.2 Central & South America Oral Proteins and Peptides Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oral Proteins and Peptides by Type
9.3 Central & South America Oral Proteins and Peptides by Application
9.4 Central & South America Oral Proteins and Peptides by Company

10 Middle East and Africa
10.1 Middle East and Africa Oral Proteins and Peptides by Countries
10.1.1 Middle East and Africa Oral Proteins and Peptides Sales by Countries
10.1.2 Middle East and Africa Oral Proteins and Peptides Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oral Proteins and Peptides by Type
10.3 Middle East and Africa Oral Proteins and Peptides by Application
10.4 Middle East and Africa Oral Proteins and Peptides by Company

11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.1.4 Oral Proteins and Peptides Product Description
11.1.5 Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.2.4 Oral Proteins and Peptides Product Description
11.2.5 Recent Development
11.3 Biocon
11.3.1 Biocon Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.3.4 Oral Proteins and Peptides Product Description
11.3.5 Recent Development
11.4 Generex Biotechnology
11.4.1 Generex Biotechnology Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.4.4 Oral Proteins and Peptides Product Description
11.4.5 Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.5.4 Oral Proteins and Peptides Product Description
11.5.5 Recent Development
11.6 Synergy Pharmaceuticals
11.6.1 Synergy Pharmaceuticals Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.6.4 Oral Proteins and Peptides Product Description
11.6.5 Recent Development
11.7 Tarsa Therapeutics
11.7.1 Tarsa Therapeutics Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.7.4 Oral Proteins and Peptides Product Description
11.7.5 Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.8.4 Oral Proteins and Peptides Product Description
11.8.5 Recent Development
11.9 Hoffmann-La Roche
11.9.1 Hoffmann-La Roche Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.9.4 Oral Proteins and Peptides Product Description
11.9.5 Recent Development
11.10 Synthetic Biologics
11.10.1 Synthetic Biologics Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Oral Proteins and Peptides
11.10.4 Oral Proteins and Peptides Product Description
11.10.5 Recent Development
11.11 Hovione
11.12 Novartis

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Oral Proteins and Peptides Raw Material
13.1.2 Oral Proteins and Peptides Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Oral Proteins and Peptides
Figure Global Oral Proteins and Peptides Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Oral Proteins and Peptides Production Market Share by Types (Product Category) in 2017
Figure Linaclotide Product Picture
Table Major Manufacturers of Linaclotide
Figure Plecanatide Product Picture
Table Major Manufacturers of Plecanatide
Figure Calcitonin Product Picture
Table Major Manufacturers of Calcitonin
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Octreotide Product Picture
Table Major Manufacturers of Octreotide
Table Global Oral Proteins and Peptides Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Gastric & Digestive Disorders
Figure Bone Diseases
Figure Diabetes
Figure Hormonal Disorders
Figure Oral Proteins and Peptides Report Years Considered
Figure Global Oral Proteins and Peptides Market Size 2016-2025 (Million US$)
Figure Global Oral Proteins and Peptides Sales 2016-2025 (K Pcs)
Table Global Oral Proteins and Peptides Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Oral Proteins and Peptides Sales by Regions 2016-2025 (K Pcs)
Table Global Oral Proteins and Peptides Sales Market Share by Regions 2016-2025
Figure Global Oral Proteins and Peptides Sales Market Share by Regions 2016-2025
Figure 2017 Global Oral Proteins and Peptides Sales Market Share by Regions
Table Global Oral Proteins and Peptides Revenue by Regions 2016-2025 (Million US$)
Table Global Oral Proteins and Peptides Revenue Market Share by Regions 2016-2025
Figure Global Oral Proteins and Peptides Revenue Market Share by Regions 2016-2025
Figure 2017 Global Oral Proteins and Peptides Revenue Market Share by Regions
Table Global Oral Proteins and Peptides Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Manufacturers (2016-2018)
Figure Global Oral Proteins and Peptides Sales Share by Manufacturers in 2017
Table Oral Proteins and Peptides Revenue by Manufacturers (2016-2018) (Million US$)
Table Oral Proteins and Peptides Revenue Share by Manufacturers (2016-2018)
Figure Oral Proteins and Peptides Value Share by Manufacturers in 2017
Table Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oral Proteins and Peptides Price (2016-2018) (USD/Pcs)
Table Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Oral Proteins and Peptides Product Category
Table Date of International Manufacturers Enter into Oral Proteins and Peptides Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Type (2016-2025)
Figure Global Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure Global Oral Proteins and Peptides Sales Market Share by Type in 2017
Table Global Oral Proteins and Peptides Revenue by Type (2016-2025) (Million US$)
Table Global Oral Proteins and Peptides Revenue Share by Type (2016-2025)
Figure Global Oral Proteins and Peptides Revenue Market Share by Type (2016-2025)
Figure Global Oral Proteins and Peptides Revenue Market Share by Type in 2017
Table Oral Proteins and Peptides Price by Type 2013-2018 (USD/Pcs)
Table Global Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Application (2016-2025)
Figure Global Sales Oral Proteins and Peptides Market Share by Application (2016-2025)
Figure Global Sales Oral Proteins and Peptides Market Share by Application (2016-2025)
Figure North America Oral Proteins and Peptides Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Oral Proteins and Peptides Revenue Growth Rate 2016-2025 (Million US$)
Table North America Oral Proteins and Peptides Sales by Countries (2016-2025) (K Pcs)
Table North America Oral Proteins and Peptides Sales Market Share by Countries (2016-2025)
Figure 2017 North America Oral Proteins and Peptides Sales Market Share by Countries
Table North America Oral Proteins and Peptides Revenue by Countries (2016-2025) (Million US$)
Table North America Oral Proteins and Peptides Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Oral Proteins and Peptides Revenue Market Share by Countries
Figure United States Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Table North America Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table North America Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure 2017 North America Oral Proteins and Peptides Market Share by Type
Table North America Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table North America Oral Proteins and Peptides Sales Market Share by Application (2016-2025)
Figure 2017 North America Oral Proteins and Peptides Market Share by Application
Table North America Oral Proteins and Peptides Sales by Company (2016-2018) (K Pcs)
Table North America Oral Proteins and Peptides Sales Market Share by Company (2016-2018)
Figure North America Oral Proteins and Peptides Sales Market Share by Company in 2017
Figure Europe Oral Proteins and Peptides Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Oral Proteins and Peptides Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Oral Proteins and Peptides Sales by Countries (2016-2025) (K Pcs)
Table Europe Oral Proteins and Peptides Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Oral Proteins and Peptides Sales Market Share by Countries
Table Europe Oral Proteins and Peptides Revenue by Countries (2016-2025) (Million US$)
Table Europe Oral Proteins and Peptides Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Oral Proteins and Peptides Revenue Market Share by Countries
Figure Germany Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure France Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table Europe Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure 2017 Europe Oral Proteins and Peptides Market Share by Type
Table Europe Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table Europe Oral Proteins and Peptides Sales Market Share by Application (2016-2025)
Figure 2017 Europe Oral Proteins and Peptides Market Share by Application
Table Europe Oral Proteins and Peptides Sales by Company (2016-2018) (K Pcs)
Table Europe Oral Proteins and Peptides Sales Market Share by Company (2016-2018)
Figure Europe Oral Proteins and Peptides Sales Market Share by Company in 2017
Figure Asia Pacific Oral Proteins and Peptides Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Oral Proteins and Peptides Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Oral Proteins and Peptides Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Oral Proteins and Peptides Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oral Proteins and Peptides Sales Market Share by Countries
Table Asia Pacific Oral Proteins and Peptides Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Oral Proteins and Peptides Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oral Proteins and Peptides Revenue Market Share by Countries
Figure China Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure China Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure India Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure India Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Oral Proteins and Peptides Market Share by Type
Table Asia Pacific Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Oral Proteins and Peptides Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Oral Proteins and Peptides Market Share by Application
Table Asia Pacific Oral Proteins and Peptides Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Oral Proteins and Peptides Sales Market Share by Company (2016-2018)
Figure Asia Pacific Oral Proteins and Peptides Sales Market Share by Company in 2017
Figure Central & South America Oral Proteins and Peptides Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Oral Proteins and Peptides Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Oral Proteins and Peptides Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Oral Proteins and Peptides Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oral Proteins and Peptides Sales Market Share by Countries
Table Central & South America Oral Proteins and Peptides Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Oral Proteins and Peptides Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oral Proteins and Peptides Revenue Market Share by Countries
Figure Brazil Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table Central & South America Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Oral Proteins and Peptides Market Share by Type
Table Central & South America Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table Central & South America Oral Proteins and Peptides Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Oral Proteins and Peptides Market Share by Application
Table Central & South America Oral Proteins and Peptides Sales by Company (2016-2018) (K Pcs)
Table Central & South America Oral Proteins and Peptides Sales Market Share by Company (2016-2018)
Figure Central & South America Oral Proteins and Peptides Sales Market Share by Company in 2017
Figure Middle East and Africa Oral Proteins and Peptides Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Oral Proteins and Peptides Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Oral Proteins and Peptides Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries
Table Middle East and Africa Oral Proteins and Peptides Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries
Figure GCC Countries Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Oral Proteins and Peptides Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Oral Proteins and Peptides Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Oral Proteins and Peptides Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Oral Proteins and Peptides Market Share by Type
Table Middle East and Africa Oral Proteins and Peptides Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Oral Proteins and Peptides Market Share by Application
Table Middle East and Africa Oral Proteins and Peptides Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Oral Proteins and Peptides Sales Market Share by Company in 2017
Table Allergan Company Details
Table Allergan Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Allergan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Biocon Company Details
Table Biocon Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Generex Biotechnology Company Details
Table Generex Biotechnology Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Generex Biotechnology Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Novo Nordisk Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Synergy Pharmaceuticals Recent Development
Table Tarsa Therapeutics Company Details
Table Tarsa Therapeutics Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Tarsa Therapeutics Recent Development
Table Sanofi Company Details
Table Sanofi Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Hoffmann-La Roche Company Details
Table Hoffmann-La Roche Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Hoffmann-La Roche Recent Development
Table Synthetic Biologics Company Details
Table Synthetic Biologics Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Synthetic Biologics Recent Development
Table Hovione Company Details
Table Novartis Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Oral Proteins and Peptides Value Chain
Table Typical Suppliers of Key Oral Proteins and Peptides Raw Material
Table Oral Proteins and Peptides Customers List
Table Oral Proteins and Peptides Sales Channels
Table Oral Proteins and Peptides Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type